Stay updated on Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe history now shows a new revision v3.5.2 added and the previous v3.5.0 revision removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check37 days agoChange DetectedAdded revision v3.5.0 to the record history. Removed revision v3.4.3 from the record history.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded Revision: v3.4.3 to the Record History and removed Revision: v3.4.2.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision entry, v3.4.2, was added to the record history, and the government funding notice banner was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check79 days agoChange DetectedThe history page now includes a government funding notice and a new revision tag (v3.4.1) while the prior revision (v3.4.0) is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check87 days agoChange DetectedUI updates include a 'Show glossary' option, visible color-coded highlights for additions and deletions, and a new revision tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

Stay in the know with updates to Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.